Sign In  |  Register  |  About San Anselmo  |  Contact Us

San Anselmo, CA
September 01, 2020 1:33pm
7-Day Forecast | Traffic

  • Search Hotels in San Anselmo

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

C O N M E D Corp (NY: CNMD )

73.68 +1.97 (+2.75%)
Streaming Delayed Price Updated: 1:33 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about C O N M E D Corp

< Previous 1 2 Next >
Assessing Conmed: Insights From 6 Financial Analysts
Via Benzinga
Peeling Back The Layers: Exploring Conmed Through Analyst Insights
Via Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Misses Revenue for Q2 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains
Ride the coattails of institutional investors with these three overlooked stocks smart money investors are piling into for triple-digit gains. 
Via InvestorPlace
$1M Bet On Skyworks Solutions? Check Out These 3 Stocks Insiders Are Buying
Via Benzinga
Analyst Scoreboard: 5 Ratings For Conmed
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Conmed
Via Benzinga
Recap: Conmed Q4 Earnings
Via Benzinga
Conmed's Earnings: A Preview
Via Benzinga
Conmed's Earnings: A Preview
Via Benzinga
CNMD Stock Earnings: Conmed Beats EPS, Beats Revenue for Q1 2024
CNMD stock results show that Conmed beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
3 Retirement Stocks to Buy at a 52-Week Low in March
Investing in these retirement stocks to buy at one-year lows presents a prime opportunity for long-term gains. 
Via InvestorPlace
Topics Retirement
Exposures Pension
These Analysts Revise Their Forecasts On CONMED After Q4 Results
CONMED Corporation (NYSE: CNMD) reported weaker-than-expected fourth-quarter financial results on Wednesday. 
Via Benzinga
AT&T To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Via Benzinga
The Latest Analyst Ratings for Conmed
Via Benzinga
2 Best Medical Device Stocks for 2023
Insulet and Conmed ought to be medtech's shining stars in 2023. 
Via The Motley Fool
Earnings Scheduled For January 31, 2024
Companies Reporting Before The Bell • Novartis (NYSE:NVS) is likely to report quarterly earnings at $1.68 per share on revenue of $11.56 billion. 
Via Benzinga
Analyst Ratings for Conmed
Via Benzinga
Where Conmed Stands With Analysts
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
Analyst Impressed With CONMED's Upbeat Q1 Performance and Raised Guidance, Bullish On Organic Growth
CONMED Corporation (NYSE: CNMD) shares are trading higher after the company reported better-than-expected  
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 27, 2023
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
CONMED Withdraws FY22 Guidance Due To Disruptions Associated With Software Implementation
Via Benzinga
What 4 Analyst Ratings Have To Say About Conmed
Analysts have provided the following ratings for Conmed (NYSE:CNMD) within the last quarter: 
Via Benzinga
Conmed's New Acquisition Is 'Door-Opener' For Orthopedic Surgery Business, This Analyst Says
Via Benzinga
Recap: Conmed Q3 Earnings
Conmed (NYSE:CNMD) reported its Q3 earnings results on Wednesday, October 26, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Conmed beat estimated earnings by... 
Via Benzinga
Domino's Pizza To Rally 20%? Here Are 5 Other Price Target Changes For Friday
Wedbush raised Domino's Pizza, Inc. (NYSE: DPZ) price target from $370 to $400. Wedbush analyst Nick Setyan maintained an Outperform rating on the stock. Domino's shares rose 10.4% to close at $333.26... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022
Upgrades 
Via Benzinga
< Previous 1 2 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 SanAnselmo.com & California Media Partners, LLC. All rights reserved.